AVIDITY BIOSCIENCES INC(NASDAQ:RNA) stock News

RNA Latest News, Press Relases and Analysis

All

Press Releases

8 days ago - By: Chartmill - Mentions: OXM OPEN WHLR VNCE ...

Thursday's session: gap up and gap down stocks

8 days ago - By: Chartmill - Mentions: OPEN WHLR KZIA AGMH ...

Discover the top movers in Thursday's pre-market session.

4 days ago - By: Avidity Biosciences, Inc.

Avidity Biosciences, Inc. Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares

4 days ago - By: Benzinga - Mentions: HAIN CHEK HSDT ATYR ...

Crude Oil Rises 1%; Manufacturing Activity in New York Falls In September

7 days ago - By: Benzinga - Mentions: QMMM SERV FUN WBD ...

IBEX, Tesla, IonQ, Warner Bros. Discovery And Other Big Stocks Moving Higher On Friday

8 days ago - By: Avidity Biosciences, Inc.

Avidity Biosciences Announces Pricing of Upsized Public Offering of Common Stock

8 days ago - By: Stocktwits - Mentions: NVS

Why Is Avidity Biosciences Stock Down 20% Pre-market Today?

9 days ago - By: Chartmill - Mentions: TC OXM CAMP DGLY ...

Wednesday's after hours session: top gainers and losers

9 days ago - By: Avidity Biosciences, Inc.

Avidity Biosciences Announces Proposed Public Offering of Common Stock

9 days ago - By: Avidity Biosciences, Inc.

Avidity Biosciences' Del-zota Demonstrated Reversal of Disease Progression Across Key Functional Endpoints in EXPLORE44® and EXPLORE44-OLE™ Phase 1/2 Trial in People Living with DMD44

14 days ago - By: Chartmill

Avidity Biosciences (NASDAQ:RNA) Exhibits High-Quality Technical Breakout Setup

23 days ago - By: Avidity Biosciences, Inc.

Avidity Biosciences to Participate in Upcoming Investor Conferences

25 days ago - By: Zacks Investment Research - Mentions: NVS BMY LLY

RNA Stock Moves More Than 30% in a Week: What's Driving This Rally?

a month ago - By: Zacks Investment Research - Mentions: CLNN

Clene Inc. (CLNN) Reports Q2 Loss, Misses Revenue Estimates

a month ago - By: Zacks Investment Research - Mentions: MRSN

Mersana Therapeutics, Inc. (MRSN) Reports Q2 Loss, Lags Revenue Estimates

a month ago - By: Zacks Investment Research - Mentions: FATE

Fate Therapeutics (FATE) Reports Q2 Loss, Beats Revenue Estimates

a month ago - By: The Motley Fool

Avidity (RNA) Q2 Revenue Jumps 88%

a month ago - By: Zacks Investment Research - Mentions: IOVA

Iovance Biotherapeutics (IOVA) Reports Q2 Loss, Lags Revenue Estimates

a month ago - By: Avidity Biosciences, Inc.

Avidity Biosciences Reports Second Quarter 2025 Financial Results and Recent Highlights

a month ago - By: Yahoo Finance - Mentions: NVS NOVN

Avidity (RNA) Gets 26% Jump on Potential Takeover

a month ago - By: Zacks Investment Research - Mentions: ARQT

Arcutis Biotherapeutics, Inc. (ARQT) Reports Q2 Loss, Beats Revenue Estimates

a month ago - By: Stocktwits - Mentions: NVS

Novartis Reportedly Eyeing To Acquire Avidity Biosciences: But Retail Expects Management To Sell Only At Significant Premium

a month ago - By: Investor's Business Daily - Mentions: NVS AAPL

Avidity Biosciences Rockets As Novartis Reportedly Mulls A Takeover Deal

2 months ago - By: Avidity Biosciences, Inc.

Avidity Biosciences Announces Completion of Enrollment for HARBOR™, the First Global Phase 3 Trial of Delpacibart Etedesiran (del-desiran) for Treatment of DM1 and Provides Guidance on Regulatory Submission

2 months ago - By: Yahoo Finance - Mentions: RJF ACHV

Raymond James Predicts Up to ~760% Surge for These 2 ‘Strong Buy’ Stocks

3 months ago - By: Yahoo Finance - Mentions: LYFT EA HSBC AVGO ...

Lyft upgraded, Block assumed: Wall Street's top analyst calls

3 months ago - By: Yahoo Finance - Mentions: RJF NET CNXC CYTK ...

Avidity Biosciences, Inc. (RNA) Initiated with a Strong Buy at Raymond James

3 months ago - By: Yahoo Finance - Mentions: JPM REGN INTC AXSM ...

AVIDITY BIOSCIENCES INC (RNA) Stock News